Seminoma Clinical Trial
Official title:
Therapeutic Strategy Guided by PET-TDM for Patients With Grade I or Metastatic Seminoma
The purpose of the study is to evaluate the ration of patients getting an lighten therapeutic strategy after 18F-fluoro-désoxyglucose positron emission tomography (PET-TDM) in grade I (cohort 1) or metastatic (cohort 2) seminoma
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06133543 -
Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer
|
N/A | |
Recruiting |
NCT05529251 -
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
|
Phase 2 | |
Completed |
NCT00705094 -
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
|
N/A | |
Active, not recruiting |
NCT03158064 -
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
|
Phase 2 | |
Active, not recruiting |
NCT01593241 -
Therapy De-escalation in Seminoma Stage IIA/B
|
Phase 2 | |
Recruiting |
NCT04876456 -
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
|
Phase 2 | |
Active, not recruiting |
NCT03937843 -
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
|
Phase 2 | |
Recruiting |
NCT04435756 -
A Study of miRNA 371 in Patients With Germ Cell Tumors
|
||
Active, not recruiting |
NCT02834013 -
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
|
Phase 2 | |
Recruiting |
NCT06309745 -
THERApy De-escalation for TESTicular Cancer
|
||
Recruiting |
NCT04914026 -
MicroRNA as Markers in Testicular Cancer
|
||
Not yet recruiting |
NCT05142982 -
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
|
N/A | |
Active, not recruiting |
NCT02375204 -
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
|
Phase 3 | |
Recruiting |
NCT06144736 -
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
|
Phase 2 | |
Recruiting |
NCT02341989 -
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
|
Phase 3 |